Brain Disease Modalities And Software Market Empowering Precision Medicine: AI-Driven Brain Disease Modalities and Software Market

Global Brain Disease Modalities and Software Market worth $21.12 Million by 2031- Exclusive Report by InsightAce Analytic

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Brain Disease Modalities And Software Market Size, Share & Trends Analysis Report By Product (Brain Imaging Modalities and Brain Analysis Software), By Type of Patients (Adults, Pediatrics and Infants), Region, Market Outlook And Industry Analysis 2031"

Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1945

According to the latest research by InsightAce Analytic, the Global Brain Disease Modalities And Software Market is valued at US$ 13.51 Billion in 2022, and it is estimated to reach US$ 21.12 Billion by 2031, with a CAGR of 5.23 % during the forecast period of 2024-2031.

Brain Disease Modalities: A Multifaceted Approach
Brain disease diagnosis relies on a variety of modalities, primarily advanced imaging techniques. These methods offer invaluable insights into brain structure and function, aiding in the detection and management of neurological disorders.

Standard Imaging Techniques:
• Magnetic Resonance Imaging (MRI): Uses radio waves and magnetic fields to produce detailed anatomical images.

• Computerized Tomography (CT) Scans: Generate detailed cross-sectional X-ray images for visualizing abnormalities like strokes and tumors.
• Positron Emission Tomography (PET) Scans: Measure brain activity by tracking the use of radiotracers.

Combining PET scans with MRI or CT scans provides even more comprehensive information. These techniques can diagnose and monitor:
• Neural activity
• Cerebral oxygenation
• Blood flow
• Strokes
• Tumors
• Traumatic brain injuries

Advanced Software for Improved Diagnosis
Brain imaging software plays a crucial role in analyzing the vast amount of data generated by these scans. By applying quantitative analysis, the software extracts detailed information about:
• Brain anatomy
• Biomarkers
• Subtle abnormalities

This quantitative approach provides valuable insights, leading to more accurate diagnoses of neurological diseases.

Enquiry Before Buying @ https://www.insightaceanalytic.com/enquiry-before-buying/1945

Market Growth Drivers
The brain disease modalities market is driven by several key factors:
• Technological Advancements: Continuous innovation in imaging techniques and artificial intelligence (AI) is transforming the field. AI algorithms are being developed to analyze scans more efficiently and accurately, improving diagnosis and treatment planning.

• Rising Neurological Disease Burden: The increasing prevalence of neurological disorders like Alzheimer's disease and dementia is driving the demand for advanced diagnostic tools.
• Demand for Safer Technologies: The non-invasive nature and safety profile of these imaging modalities are significant advantages over traditional methods.

Market Challenges:
Despite the positive trends, some challenges persist:
• COVID-19 Impact: The pandemic initially caused a decline in demand for some neuroimaging services due to resource allocation towards COVID-19 testing and respiratory imaging.

• Helium Shortage: Helium gas is essential for certain MRI machines. Scarcity can disrupt device operation and performance.

• Economic Disparity: The high cost of these technologies and testing can limit access for some patients.

Looking Ahead
The brain disease modalities market is expected to continue growing as advancements in technology address existing challenges and improve affordability. This will lead to more accurate diagnoses, improved patient outcomes, and a deeper understanding of brain function and disease.

North America and Europe are reported as the most significant shareholder of the brain diseases modalities and software market in 2022, while the Asia-Pacific region is expecting to grow at a higher CAGR due to the applications, technology, and end-use.

Competitive Landscape
Some of The Key Players in The Brain disease modalities and software Market:

• Quantib
• Brainomix
• Qure.AI
• General Electric Company
• Imaging Biometrics, LLC
• United Imaging Healthcare Co. Ltd.
• Siemens
• Healthineers AG
• Koninklijke Philips N.V.
• Canon Inc.
• Vuno Co. Ltd.
• Aspect Imaging
• IXICO
• QMENTA
• Cortechs.ai
• A.I. Analysis Inc.
• Fujifilm Holdings Corporation
• Other Prominent Players.

Key developments
• In Mar 2023, Brainomix declared that the FDA had approved its Brainomix 360 e-ASPECTS tool for stroke, allowing the Oxford-based business to introduce its cutting-edge stroke AI imaging technology to US stroke facilities.

• In Jan 2022, Quantib introduced a substantial upgrade to its AI-powered solution for brain atrophy and white matter hyperintensity progression called Quantib® ND 2.0. This upgrade was made possible by the company's commitment to continuous research and development. The solution has been given authorization by the FDA for use in clinical settings in the United States.

• In Nov 2021, Siemens Healthineers Launches World's First CT Scanner 'NAEOTOM Alpha' With Photon-Counting Technology. The photon-counting technology enables drastic improvements in radiation dose by up to 45 percent rise in reduction and resolution for ultra-high resolution (UHR) scans compared with traditional CT detectors.

Market Segments
Global Brain disease modalities and software Market segmented by Products, 2023-2031 (Value US$ Mn)
• Brain analysis software
 PET Devices
 CT Devices
 MRI Devices
 PET-CT
 PET-MRI
• Brain imaging modalities
Global Brain disease modalities and software Market segmented by Type of Patients, 2023-2031 (Value US$ Mn)
• Adults
• Pediatrics
• Infants
Global Brain disease modalities and software Market segmented by End-User, 2023-2031 (Value US$ Mn)

• Hospitals and clinics
• Ambulatory surgery centers
• Diagnostic imaging centers

Global Brain disease modalities and software Market segmented by Region, 2023-2031 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global protein design and engineering market
 To receive an industry overview and future trends of the protein design and engineering market
 To analyze the protein design and engineering market drivers and challenges
 To get information on the protein design and engineering market size (Value US$ Mn) forecast to 2031
 Significant investments, mergers & acquisitions in the protein design and engineering market industry

For More Information @ https://www.insightaceanalytic.com/report/brain-disease-modalities-and-software-market/1945

Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

This release was published on openPR.